Royal Bank of Canada and Leerink Partners lowered price targets and ratings for Boston Scientific.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada and Leerink Partners lowered price targets and ratings for Boston Scientific.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
-
Royal Bank of Canada
financial institution in Canada
Related events
- Financial firms, including RBC, TD Cowen, Leerink Partners, and Morgan Stanley, raised price targets and provided coverage for Vertex Pharmaceuticals.
- Royal Bank of Canada lifted its target price for Ashanti.
- Royal Bank of Canada lifted its target price for Ford.
- Royal Bank of Canada lifted its target price for MMM.
- Royal Bank of Canada upped its target price for Citizens Financial Group.